Named on one round in the feed.
Since 2026-01-28
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$257M
across 1 round
CO-INVESTORS
10
named beside it
Named on one round in the feed.
Since 2026-01-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $257M | 2026-01-28 | [ PART ] |
No sector on record.